CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Diapulse Corporation of America is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Diapulse Corporation of America
475 Northern Blvd
Phone: (516) 466-3030p:516 466-3030 GREAT NECK, NY  11021  United States Fax: (516) 829-8069f:516 829-8069
On 9/12/2013, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of Diapulse Corporation of America Inc for failure to make required periodic filings with the Commission.
This company is no longer actively traded on any major stock exchange.
Business Summary
Diapulse Corporation of America manufactures, researches and develops Diapulse medical technology. It is indicated for the adjunctive use in the palliative treatment of postoperative edema and pain in superficial soft tissues in acute and chronic wounds. Diapulse is Medicare Covered to treat Stage III and IV pressure ulcers, venous stasis ulcers, arterial ulcers, and diabetic ulcers in hospitals, nursing homes, therapy clinics and physician offices. Diapulse is pulsed non-thermal electromagnetic therapy.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/200812/31/2007YesYes---

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, CEO, Principal Financial Officer, Treasurer, Secretary David M.Ross 63 1/22/2008 1/1/1989
Director AbrahamJaeger 62 8/21/2007 8/21/2007
Director Jonathan E.Ross 26 8/21/2007 8/21/2007

General Information
Number of Employees: 2 (As of 12/31/2007)
Outstanding Shares: 3,960,730 (As of 11/11/2008)
Shareholders: 1,407
Stock Exchange: OTC
Federal Tax Id: 135671991
Fax Number: (516) 829-8069
Email Address: diapulse@aol.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023